13/06/2026
This is why we use a medical grade NovoTHOR Whole-Body bed. The wavelength, light strength and time have been properly researched. Which is why NovoTHOR has FDA approval in the USA and is used for medical research.
Appointments for NovoTHOR
Telephone 01926 335932
Red light therapy works through a real target inside your mitochondria, and it has a ceiling most people walk straight past. More is not better here. Past the optimal dose, the same light that was raising a cell's energy output starts shutting it down.
Cytochrome c oxidase, the final enzyme in the mitochondrial electron transport chain, is the main molecule that absorbs red and near-infrared light. The widely accepted account is that the light dissociates a molecule of inhibitory nitric oxide sitting on that enzyme. With the brake released, the electron chain runs faster and ATP production rises. That step is the engine behind the wound healing, pain relief, and skin effects the therapy is used for.
The biphasic dose response is the organizing principle of the entire field, reproduced often enough to have a name, the Arndt-Schulz curve. Low doses stimulate and repair tissue, while higher doses of the same light have an inhibitory effect. The benefit climbs to a peak and then falls back below zero, so the relationship between dose and result is an arch, not a ladder.
The reason the high end turns inhibitory is not actually settled, and it is worth being precise rather than inventing a mechanism. The reactive oxygen story is a good example of how context-dependent this is. The same light produces a brief burst of reactive oxygen species in healthy cells, yet in oxidatively stressed cells and animal models of disease it lowers reactive oxygen levels and raises antioxidant defenses. The cell's starting state changes the direction of the effect.
A controlled trial in 136 people found that red and near-infrared treatment improved intradermal collagen density and reduced fine lines and skin roughness. The therapy has reasonable support for skin, wound healing, and certain kinds of pain and inflammation, which is exactly why the dosing question matters instead of being academic.
The failure mode is treating more as better, standing closer, running it longer, buying a brighter panel, and using it more often, all of which push you up and over the peak toward the flat or inhibitory part of the curve. Wavelength, intensity, distance, and time are the variables that decide whether a session lands in the helpful zone, and getting them wrong is a large part of why the literature contains so many negative trials next to the positive ones. One widely cited review on this point was co-authored by the owner of a company that sells these devices, and the biphasic finding holds across independent groups regardless. The device is not the hard part. The dose is.
References: Hamblin, AIMS Biophysics, 2017 Huang et al., Dose-Response, 2009 Chung et al., Annals of Biomedical Engineering, 2012 Wunsch and Matuschka, Photomedicine and Laser Surgery, 2014
